NSC714187 is primarily investigated for its potential in cancer research, particularly as an inhibitor of specific biological pathways involved in tumor growth and proliferation. It has shown promise in preclinical studies for targeting certain enzymes or proteins that are critical for the survival of cancer cells, making it a candidate for further development in oncology therapeutics. Researchers are exploring its efficacy in combination with other treatments to enhance its anti-cancer effects. Additionally, NSC714187 is being studied for its role in modulating cellular processes that could be relevant in other diseases, such as inflammatory or autoimmune conditions. Its application is still largely experimental, with ongoing studies aimed at understanding its mechanisms and optimizing its therapeutic potential.